TNF and enthesitis: In addition to blood samples, other studies explored various predictors to forecast treatment efficiency, revealing factors like secukinumab dosage, prior anti-tumor necrosis factor (TNF) treatment, methotrexate usage, baseline enthesitis, PsA disease duration, and PASI score [79,80].